Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan;13(1):6-17.
doi: 10.2450/2014.0063-14. Epub 2014 Sep 12.

Hepatitis E: an old infection with new implications

Affiliations
Review

Hepatitis E: an old infection with new implications

Giuseppe Marano et al. Blood Transfus. 2015 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic representation of the genomic organisation of the hepatitis E virus (HEV). ORF: open reading frame; MT: methyltransferase; Y: Y domain; PCP: a papain-like cysteine protease; Hel: helicase; HVR: hypervariable region; X: macro-domain; RdRp: RNA-dependent RNA polymerase; JR: junction region; SL: stem-loop structure; NCR: non-coding region. Modified from Cao D et al., 2010.
Figure 2
Figure 2
Worldwide distribution of hepatitis E virus infection per genotype (Gt). Modified from Kamar N et al., 2012.
Figure 3
Figure 3
Schematic representation of the course of acute HEV infection. HEV RNA becomes detectable in stools and serum during the incubation period, with the subsequent appearance of IgM and IgG HEV antibodies. The level of IgM antibodies peaks early and then these antibodies become undetectable during recovery, whereas the level of IgG antibodies keeps on increasing and can persist in the long term. Clinical symptoms (fatigue, nausea, and jaundice) begin shortly after the increase of serum alanine aminotransferase (ALT) levels. HEV RNA disappears from the serum with recovery, whereas the virus usually remains detectable longer in stools (arrows). Modified from Hoofnagle JH, 2012.

References

    1. Picker SM. Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfus. 2013;11:343–8. - PMC - PubMed
    1. Stramer SL, Dodd RY for the AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013;53:2375–83. - PMC - PubMed
    1. Liumbruno GM, Calteri D, Petropulacos K, et al. The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus. 2008;6:199–210. - PMC - PubMed
    1. Grazzini G, Liumbruno GM, Pupella S, et al. West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus. 2008;6:235–7. - PMC - PubMed
    1. Pupella S, Pisani G, Cristiano K, et al. West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008–2012 and their impact on blood safety. Blood Transfus. 2013;11:563–74. - PMC - PubMed

MeSH terms